Published in Transfusion on September 17, 1992
Characterizing the epidemiology of postoperative transfusion-related acute lung injury. Anesthesiology (2015) 1.76
Perioperative blood transfusion: a plea for guidelines. Ann R Coll Surg Engl (1997) 1.45
Transfusion-related acute lung injury (TRALI): current concepts and misconceptions. Blood Rev (2009) 1.26
Regional transfusion centre preoperative autologous blood donation programme: the first two years. BMJ (1992) 1.24
Retrospective evaluation of adverse transfusion reactions following blood product transfusion from a tertiary care hospital: A preliminary step towards hemovigilance. Asian J Transfus Sci (2013) 1.23
Long-term survival and quality of life after transfusion-associated pulmonary edema in critically ill medical patients. Chest (2009) 1.18
Red blood cell transfusions and the risk of acute respiratory distress syndrome among the critically ill: a cohort study. Crit Care (2007) 1.14
Transfusion-Related Acute Lung Injury: Incidence, Pathogenesis and the Role of Multicomponent Apheresis in Its Prevention. Transfus Med Hemother (2008) 1.05
Transfusion-related acute lung injury in multiple traumatized patients. Caspian J Intern Med (2012) 0.91
Transfusion-related acute lung injury (TRALI): current clinical and pathophysiologic considerations. Lung (2006) 0.84
Transfusion-related acute lung injury in the Canadian paediatric population. Paediatr Child Health (2012) 0.83
The management of hospitalized patients with cirrhosis: the Mount Sinai experience and a guide for hospitalists. Dig Dis Sci (2011) 0.82
Transfusion-related acute lung injury. Transfusion (1993) 0.78
Impact of Transfusion on Cancer Growth and Outcome. Cancer Growth Metastasis (2016) 0.77
Possible transfusion-related acute lung injury (TRALI) in cardiac surgery patients. Croat Med J (2014) 0.77
Assessment of Intraoperative Blood Loss during Oral and Maxillofacial Surgical Procedures in a Nigerian Tertiary Health Care Center. J Blood Transfus (2014) 0.75
Cumulative effect in transfusion related acute lung injury. Saudi J Anaesth (2012) 0.75
Bad blood: a trigger for TRALI. Nat Med (2010) 0.75
Therapeutic options for transfusion related acute lung injury; the potential of the G2A receptor. Curr Pharm Des (2012) 0.75
Autologous transfusion and reducing allogeneic blood exposure. Arch Dis Child (1994) 0.75
Diagnostic and pathogenetic considerations in transfusion-related acute lung injury. Transfusion (1985) 3.35
A comparison of plasmapheresis versus high-dose IVIG desensitization in renal allograft recipients with high levels of donor specific alloantibody. Am J Transplant (2006) 2.37
Major histocompatibility complex class II alleles and the course and outcome of MS: a population-based study. Neurology (1998) 2.26
Eosinophilic fasciitis: clinical spectrum and therapeutic response in 52 cases. Semin Arthritis Rheum (1988) 1.70
Transfusion-related acute lung injury associated with passive transfer of antileukocyte antibodies. Am Rev Respir Dis (1983) 1.68
Hypotensive reactions: are they a new phenomenon? Are they related solely to transfusion of platelets? Does filtration of components play a role? Transfusion (1996) 1.62
Autoimmune cholangitis within the spectrum of autoimmune liver disease. Hepatology (2000) 1.55
DR human leukocyte antigens and disease severity in chronic hepatitis C. J Hepatol (1996) 1.54
Perioperative blood transfusion and colorectal cancer recurrence: a qualitative statistical overview and meta-analysis. Transfusion (1993) 1.49
Genetic distinctions between types 1 and 2 autoimmune hepatitis. Am J Gastroenterol (1997) 1.49
Ischemic-type biliary complications after orthotopic liver transplantation. Hepatology (1992) 1.46
Elevated serum levels of the eosinophil granule major basic protein in patients with eosinophilia. J Clin Invest (1981) 1.46
Host- and disease-specific factors affecting steatosis in chronic hepatitis C. J Hepatol (1998) 1.43
Transplant glomerulopathy: subclinical incidence and association with alloantibody. Am J Transplant (2007) 1.40
Morning admission to the hospital for surgery the same day. A practical problem for the blood bank. Transfusion (1987) 1.39
Evidence against hepatitis viruses as important causes of severe autoimmune hepatitis in the United States. J Hepatol (1993) 1.29
RBC alloantibody specificity and antigen potency in Olmsted County, Minnesota. Transfusion (2001) 1.28
Delayed hemolytic transfusion reactions. Evidence of the need for an improved pretransfusion compatibility test. Am J Clin Pathol (1980) 1.24
Linkage evidence for genetic heterogeneity among kinships with hereditary motor and sensory neuropathy, type I. Mayo Clin Proc (1983) 1.24
Associations between alleles of the major histocompatibility complex and type 1 autoimmune hepatitis. Hepatology (1997) 1.16
The syndrome of gastric argyrophil carcinoid tumors and nonantral gastric atrophy. Ann Intern Med (1983) 1.15
Allelic basis for HLA-encoded susceptibility to type 1 autoimmune hepatitis. Gastroenterology (1997) 1.15
Histologic findings one year after positive crossmatch or ABO blood group incompatible living donor kidney transplantation. Am J Transplant (2006) 1.12
Increased bile duct complications in liver transplantation across the ABO barrier. Ann Surg (1993) 1.11
The dose of infused lymphocytes in the autograft directly correlates with clinical outcome after autologous peripheral blood hematopoietic stem cell transplantation in multiple myeloma. Leukemia (2004) 1.10
Influence of positive lymphocyte crossmatch and HLA mismatching on vanishing bile duct syndrome in human liver allografts. Transplantation (1988) 1.10
Trends in the incidence of delayed hemolytic and delayed serologic transfusion reactions. Transfusion (1999) 1.09
Delayed immune hemolysis in a patient receiving cyclosporine after orthotopic liver transplantation. Transfusion (1988) 1.07
Universal WBC reduction. Transfusion (2000) 1.06
Coronary artery disease in twins. Br Heart J (1981) 1.05
Mayo Clinic experience with allogeneic and syngeneic bone marrow transplantation, 1982 through 1990. Mayo Clin Proc (1992) 1.05
Infused peripheral blood autograft absolute lymphocyte count correlates with day 15 absolute lymphocyte count and clinical outcome after autologous peripheral hematopoietic stem cell transplantation in non-Hodgkin's lymphoma. Bone Marrow Transplant (2004) 1.05
Evidence that the liver does not always protect the kidney from hyperacute rejection in combined liver-kidney transplantation across a positive lymphocyte crossmatch. Transplantation (1990) 1.04
The nature and prognosis of severe cryptogenic chronic active hepatitis. Gastroenterology (1993) 1.04
Origin of chi46,XX/46,XY chimerism in a human true hermaphrodite. Science (1980) 1.03
Genetic predispositions for the immunological features of chronic active hepatitis. Hepatology (1993) 1.01
Immunologic features and HLA associations in chronic viral hepatitis. Gastroenterology (1995) 0.99
Significance of HLA DR4 in type 1 autoimmune hepatitis. Gastroenterology (1993) 0.98
Palpation thyroiditis (multifocal granulomatour folliculitis). Am J Clin Pathol (1975) 0.97
Plasma exchange conditioning for ABO-incompatible renal transplantation. J Clin Apher (2004) 0.96
Serum IgG anti-native type II collagen antibodies in rheumatoid arthritis: association with HLA DR4 and lack of clinical correlation. Clin Exp Rheumatol (1989) 0.95
Hemochromatosis: genetic or alcohol-induced? Gastroenterology (1983) 0.94
Kidney transplantation in patients with antibodies against donor HLA class II. Am J Transplant (2007) 0.94
Associations of antibodies to native DNA with HLA-DRw3. A possible major histocompatibility complex-linked human immune response gene. J Exp Med (1980) 0.93
Immunologic, clinical, and pathologic aspects of human graft-versus-host disease. Mayo Clin Proc (1983) 0.91
Prevalence of TT virus infection in blood donors with elevated ALT in the absence of known hepatitis markers. Am J Gastroenterol (2000) 0.90
Mixed lymphocyte culture, phytohemagglutinin stimulation, and matching grade: clinical relevance in renal transplantation from living related donors. Transplantation (1980) 0.90
Severe ductopenic rejection following liver transplantation: incidence, time of onset, risk factors, treatment, and outcome. Semin Liver Dis (1992) 0.90
HLA and nasopharyngeal carcinoma in North American Caucasoids. Tissue Antigens (1983) 0.89
Lack of association between Behçet's disease and major histocompatibility complex class II antigens in an ethnically diverse North American Caucasoid patient group. J Rheumatol (1986) 0.88
Persistent centrilobular necroses in hepatic allografts. Hum Pathol (1990) 0.88
Apheresis instrument settings influence infused absolute lymphocyte count affecting survival following autologous peripheral hematopoietic stem cell transplantation in non-Hodgkin's lymphoma: the need to optimize instrument setting and define a lymphocyte collection target. Bone Marrow Transplant (2006) 0.88
In search of marker for genetic susceptibility to reflux nephropathy. Clin Nephrol (1980) 0.88
HLA-DR locus antigens in polymyalgia rheumatica and giant cell arteritis. J Rheumatol (1982) 0.87
Delayed hemolysis resulting from anti-A1 after liver transplantation. Am J Clin Pathol (1989) 0.87
Blood transfusion and septic complications after hip replacement surgery. Transfusion (1995) 0.86
Comparison of the polyethylene glycol antiglobulin test and the use of enzymes in antibody detection and identification. Transfusion (1996) 0.85
Primary biliary cirrhosis: associations with class II major histocompatibility complex antigens. Hepatology (1987) 0.85
The differentiation of delayed hemolytic and delayed serologic transfusion reactions: incidence and predictors of hemolysis. Transfusion (1995) 0.85
Anti-type II collagen antibodies in rheumatoid arthritis. The influence of HLA phenotype. Tissue Antigens (1984) 0.85
Blood transfusion and postoperative septic complications. Transfusion (1994) 0.85
HLA-DRB1 molecules and antigenic experience shape the repertoire of CD4 T cells. Hum Immunol (1995) 0.84
Association between major histocompatibility antigen and reproductive performance. Am J Reprod Immunol Microbiol (1987) 0.84
Genetic predispositions for immunological features in chronic liver diseases other than autoimmune hepatitis. J Hepatol (1996) 0.84
Anaphylactic transfusion reactions--a concise review. Ir Med J (1985) 0.84
Myelin oligodendrocyte glycoprotein antibodies in pathologically proven multiple sclerosis: frequency, stability and clinicopathologic correlations. Mult Scler (2007) 0.83
How important are ABO-related variations in coagulation factor levels? Transfusion (2001) 0.83
Roles of the neutrophil and other mediators in adult respiratory distress syndrome. Mayo Clin Proc (1989) 0.83
Blood transfusion and risk of non-Hodgkin's lymphoma. Am J Epidemiol (1999) 0.82
Evidence for linkage of IgA deficiency with the major histocompatibility complex. Mayo Clin Proc (1988) 0.82
Immune phenotype of chronic liver disease. Dig Dis Sci (1998) 0.82
Progressive apraxia in clinically discordant monozygotic twins. Arch Neurol (1995) 0.81
Thrombocytopenia after liver transplantation. Transplant Proc (1988) 0.81
Investigating unexplained infertility. Am J Obstet Gynecol (1988) 0.80
Confounding and the effect of allogeneic transfusion on survival. Vox Sang (1995) 0.80
The association between HLA class I alleles and measles vaccine-induced antibody response: evidence of a significant association. Vaccine (1998) 0.80
Effect of autologous transfusion on length of survival. Vox Sang (1995) 0.80
Autologous transfusion in Jehovah's Witnesses. Transfusion (1985) 0.79
What is the incidence of perioperative transfusion-related acute lung injury? Anesthesiology (1995) 0.79
Immunologic mechanisms in the maternal-fetal relationship. Mayo Clin Proc (1986) 0.79
Heterogeneity of HLA-BW35 based on the diallelic BW4-BW6 system. Mayo Clin Proc (1979) 0.78
Transfusion-related acute lung injury. Transfusion (1993) 0.78
Severe thrombocytopenia in Epstein-Barr virus-induced mononucleosis. West J Med (1989) 0.78
Prestorage leukocyte depletion: effect on leukocyte and platelet metabolites, erythrocyte lysis, metabolism, and in vivo survival. Semin Hematol (1991) 0.78
Mechanism of transfusion-related acute lung injury. Blood (1991) 0.78
The role of the Lewis antigen system in renal transplantation and allograft rejection. Mayo Clin Proc (1984) 0.77
Lack of association between cytomegalovirus infection, HLA matching and the vanishing bile duct syndrome after liver transplantation. Hepatology (1992) 0.77
Corrective and preventive action. Transfus Sci (1999) 0.77
Homologous blood transfusion in patients with prostate cancer: no effect on tumor progression or survival. Urology (1994) 0.77
Significance of human leukocyte antigens DR3 and DR4 in chronic viral hepatitis. Dig Dis Sci (1995) 0.76
HLA-DQ associations in type 1 autoimmune hepatitis. Mayo Clin Proc (1995) 0.76
High frequency of HLA-A*0103 allele in a Somali population. Hum Immunol (2001) 0.76
AIDS, blood transfusions, and directed donations. N Engl J Med (1986) 0.76
HLA. Mayo Clin Proc (1979) 0.76
Transfusion-induced alloimmunization in patients awaiting renal allografts. Vox Sang (1984) 0.76
What are we teaching about indigent patients? JAMA (1993) 0.75
Antagonists of cyclic nucleotide phosphodiesterase (PDE) isozymes PDE 3 and PDE 4 suppress lymphoblastic response to HLA class II alloantigens: a potential novel approach to preventing allograft rejection? Clin Nephrol (1997) 0.75
HLA epitope matching: a new way of evaluating an old matching system. Transfusion (1992) 0.75